Search Criteria : United States of America Amherst
Betting on BTK Inhibitors in chronic lymphocytic leukemia CLL: Where are We Now and Where are We Going?
Oct 25, 2020 | Contact Hours 1 | Amherst, New Hampshire
Betting on BTK Inhibitors in chronic lymphocytic leukemia CLL: Where are We Now and Where are We Going? is organized by Creative Educational Concepts (CEC), Inc. and will be held on Oct 25, 2020 at Merchant Logo LaBelle Winery, Amherst, New Hampshire, United States of America. Accreditation: Pharmacy (ACPE): This application-based activity is approved for 1.0 contact hours (.10 CEUs) of continuing pharmacy education credit (JA0007101-0000-20-001-L01-P). Overview: This initiative is targeted to addressing the professional practice of pharmacists in hospitals, health systems, ambulatory care clinics, and other settings. Attendees of this activity will gain insight into the latest clinical and scientific advances in the treatment and management of patients with chronic lymphocytic leukemia (CLL) using BTK inhibitors (BTKis), including the latest approvals, the most current safety and efficacy data, and expert insights into addressing challenges of CLL treatment using BTKis. Using a case-based approach, discussion on anticipating and managing adverse events, therapy selection, and improving adherence will be incorporated into this cutting-edge activity. Additional details will be posted as soon as information is available.